Querfurth, H.W.; Lemere, C.; Ciola, J.; Havas, D.; Xia, W.; Lee, H.K.
Target Validation Studies of PS48, a PDK-1 Allosteric Agonist, for the Treatment of Alzheimer’s Disease Phenotype in APP/PS1 Transgenic Mice. Int. J. Mol. Sci. 2025, 26, 3473.
https://doi.org/10.3390/ijms26083473
AMA Style
Querfurth HW, Lemere C, Ciola J, Havas D, Xia W, Lee HK.
Target Validation Studies of PS48, a PDK-1 Allosteric Agonist, for the Treatment of Alzheimer’s Disease Phenotype in APP/PS1 Transgenic Mice. International Journal of Molecular Sciences. 2025; 26(8):3473.
https://doi.org/10.3390/ijms26083473
Chicago/Turabian Style
Querfurth, Henry W., Cynthia Lemere, Jason Ciola, Daniel Havas, Weiming Xia, and Han Kyu Lee.
2025. "Target Validation Studies of PS48, a PDK-1 Allosteric Agonist, for the Treatment of Alzheimer’s Disease Phenotype in APP/PS1 Transgenic Mice" International Journal of Molecular Sciences 26, no. 8: 3473.
https://doi.org/10.3390/ijms26083473
APA Style
Querfurth, H. W., Lemere, C., Ciola, J., Havas, D., Xia, W., & Lee, H. K.
(2025). Target Validation Studies of PS48, a PDK-1 Allosteric Agonist, for the Treatment of Alzheimer’s Disease Phenotype in APP/PS1 Transgenic Mice. International Journal of Molecular Sciences, 26(8), 3473.
https://doi.org/10.3390/ijms26083473
